- Home
- HST vs RVTY Comparison
HST vs RVTY Comparison
Compare HST & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HST | RVTY |
|---|---|---|
| Founded | 1927 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 12.7B |
| IPO Year | 1998 | 1994 |
Fundamental Metrics
Financial Performance| Metric | HST | RVTY |
|---|---|---|
| Price | $22.49 | $126.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | $20.75 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 9.6M | 1.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.51% | 0.34% |
| EPS Growth | ★ 11.11 | N/A |
| EPS | ★ 1.06 | 0.82 |
| Revenue | ★ $5,387,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $0.10 | $6.37 |
| Revenue Next Year | $1.09 | $5.10 |
| P/E Ratio | ★ $21.70 | $152.24 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.61 | $81.22 |
| 52 Week High | $25.71 | $124.97 |
Technical Indicators
Market Signals| Indicator | HST | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 38.67 | 67.62 |
| Support Level | $22.46 | $92.94 |
| Resistance Level | $23.42 | N/A |
| Average True Range (ATR) | 0.44 | 3.29 |
| MACD | -0.03 | 0.76 |
| Stochastic Oscillator | 31.75 | 97.33 |
Price Performance
Historical ComparisonAbout HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 78 predominantly urban and resort upper-upscale and luxury hotel properties representing over 42,000 rooms, mainly in the United States. Host sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.